Search
Regulatory Story
Company Halma PLC
TIDM HLMA
Headline Trading Statement
Released 07:00 25-Sep-2019
Number 5313N07

RNS Number : 5313N
Halma PLC
25 September 2019
 

Halma, the FTSE100 group of life-saving technology companies, today releases its scheduled trading update, for the period from 1 April 2019 to date, and is also updating on recent management changes on its Executive Board.

 

Trading Update

 

Halma made good progress in this period. The Group's performance was in line with the Board's expectations and included further organic constant currency revenue growth against a strong comparative period in the first half of 2019. Order intake was ahead of revenue and was also ahead of the same period last year.

 

All sectors delivered organic constant currency revenue growth. The Environmental & Analysis sector performed well, while the Medical and Infrastructure Safety sectors saw more modest rates of growth.  Revenue growth in Process Safety was in line with the second half of last year.

 

There was widespread growth geographically, with organic constant currency revenue increases in all major regions. There were good rates of growth in the UK and the USA, with more moderate growth in Europe and Asia-Pacific. The weakness of Sterling is having a positive currency translation effect on the Group's results (see Note 2).

 

Cash generation remains strong and our financial position remains robust, allowing us to support continued investment in growth, both organically and by acquisition.

 

We have a healthy acquisition pipeline and our M&A teams continue to be active. In July, we announced that we had completed the acquisition of the Ampac Group, a leading fire and evacuation systems supplier in the Australian and New Zealand markets, for A$135 million (£74 million) on a cash and debt free basis. We also made two small bolt-on acquisitions in the period in the UK and France, both in the Environmental & Analysis sector, for a maximum total consideration of c.£7 million. The integrations of these acquisitions are progressing well.

 

The results for the half year ending 30 September 2019 will be released on 19 November 2019.

 

Executive Board Changes

 

During the period there have been three changes to Halma's Executive Board arising from planned succession processes and the evolution of our operational and digital growth strategies.

 

Sector Chief Executive

 

Laura Stoltenberg will succeed Adam Meyers as Sector Chief Executive, Medical & Environmental from 1st October 2019. This Sector Chief Executive role will be a member of the Halma Executive Board.

 

Laura joined Halma as Divisional Chief Executive, Medical & Environmental on January 1, 2019 from Medtronic where she was Vice President and General Manager for MDI Solutions at Medtronic Diabetes. Prior to Medtronic, Laura was Chief Commercial Officer at Exact Sciences Corporation, responsible for sales, marketing, market access and medical affairs. Earlier in her career she held escalating leadership roles at General Electric, including GE Healthcare Lunar, and drove several acquisitions for GE Healthcare.

 

As announced in July 2019, Adam will support Laura in her transition to ensure an orderly handover occurs and he will remain on the Executive Board and the plc Board until July 2020. He has agreed to support Halma beyond this date until mid-2021 should we need it.

 

Group General Counsel and Company Secretary

 

Ruwan De Soyza has joined Halma as our General Counsel and Company Secretary following the retirement of Carol Chesney. This is a newly created role on Halma's Executive Board, with global responsibility for the Group's legal, compliance, governance and company secretarial affairs.

 

Before joining Halma, Ruwan was the Deputy General Counsel and Head of Public Policy and Government Affairs at Worldpay Inc, the NYSE listed payment processing company, having been Group General Counsel of Worldpay Group plc. Prior to that, Ruwan held positions at Standard Chartered Bank, Accenture and Clifford Chance LLP. He holds a Diploma in Law and a Mechanical Engineering degree and is qualified as a solicitor in England and Wales.

 

Chief Technology Officer

 

Catherine Michel has joined Halma as our first Chief Technology Officer, a newly created role on Halma's Executive Board, with global responsibility for IT and digital architecture. Prior to joining Halma, Catherine was Chief Technology Officer and Chief Strategy Officer at Sigma Systems. Catherine began her career at Accenture and was founder and CTO of Tribold (later acquired by Sigma Systems in 2013). Catherine will work closely with Inken Braunschmidt in her role of driving the execution of Halma's Digital and Innovation strategy.

 

Andrew Williams, Halma's CEO commented:

 

'These appointments bring important new capabilities to our Executive Board which are aligned with our organic and acquisition growth strategies. Laura, Ruwan and Catherine have all demonstrated a strong understanding of Halma's unique operating culture and will work closely with our sector and company Boards to help them achieve their growth ambitions.'

 

For further information, please contact:

 

 

Halma plc

 

Andrew Williams, Chief Executive

On 25 September:  +44 (0)7776 685948

Marc Ronchetti, Chief Financial Officer

Thereafter: +44 (0)1494 721111

Charles King, Head of Investor Relations

 

 

MHP Communications

 

Rachel Hirst/ Andrew Jaques

+44 (0)20 3128 8100

 

 

About Halma

 

Halma is a global group of life-saving technology companies, focused on creating a safer, cleaner and healthier future for people worldwide. Our innovative products and solutions address many of the key issues facing the world today. We operate in four sectors: Process Safety, Infrastructure Safety, Environmental & Analysis and Medical. We employ over 6,000 people in 20 countries, with major operations in Europe, the USA and Asia-Pacific. We target global niche markets where sustainable growth and high returns are supported by long-term drivers. Halma is listed on the London Stock Exchange and has been a member of the FTSE 100 index since December 2017.

 

Notes:

 

1.   This Trading Update is based upon unaudited management accounts information. Forward-looking statements have been made by the Directors in good faith using information available up until the date that they approved this statement. Forward-looking statements should be regarded with caution because of the inherent uncertainties in economic trends and business risks.

2.   Sterling has weakened in the period relative to many currencies, including the US Dollar and Euro. If current exchange rates continue throughout the rest of the current financial year the currency translation impact on the Group's results is expected to be positive. Based on the mix of currency denominated revenue and profit for the 2019 financial year, a 1% movement in the US Dollar changes full year revenue by £5.5m and profit by £1.1m. Similarly, a 1% movement in the Euro changes full year revenue by £1.5m and profit by £0.3m. The weighted average exchange rates relative to Sterling used to translate revenue and profit for the year ended 31 March 2019 were: US Dollar 1.31, Euro 1.14.

 

3.   Halma will be hosting a site visit for analysts and investors on 1 October to its HWM Water subsidiary's headquarters in Cwmbran, Wales.  A summary of the presentation will be posted on our website, www.halma.com, on that day.

 

4.   A copy of this announcement, together with other information about Halma, may be viewed on its website at www.halma.com


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTBLGDCBXDBGCS
London Stock Exchange plc is not responsible for and does not check content on this Website. Website users are responsible for checking content. Any news item (including any prospectus) which is addressed solely to the persons and countries specified therein should not be relied upon other than by such persons and/or outside the specified countries. Terms and conditions, including restrictions on use and distribution apply.